Table 4. Complications Associated with AF after ACS.
HR=Hazard Ratio, OR=Odds Ratio, N/A=Data Not Available, CVA=Cerebrovascular Accident, CHF=Congestive Heart Failure, VT=Ventricular Tachycardia, VF=Ventricular Fibrillation.
| Author/Study | Publication Date | Follow-up | CVA | Length of Hospital Stay | In-Hospital Re-infarction | Major Bleeding | CHF | Cardiogenic Shock | VT | VF |
|---|---|---|---|---|---|---|---|---|---|---|
| Lau/ACACIA | 2009 | N/A | N/A | 9.7 days vs 5.5 days | OR 3.7(2.0-7.0) | OR 5.8(3.1-10.6) | OR 3.1(1.7-5.7) | N/A | N/A | N/A |
| Lopes | 2008 | 30 days | NSTEMI HR 3.45(2.41-4.95), STEMI HR 1.46(1.17- | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Siu | 2007 | 2 year | HR 5.1(2.4-11.2) | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Kober/VALIANT | 2006 | 3 year | 8.1% AF vs 3.7% no AF | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Lehto/OPTIMAAL | 2005 | 30 day | HR 14.6(5.87-36.3) | 14.1 days vs 12.3 days | N/A | N/A | N/A | N/A | N/A | N/A |
| Kinjo/OACIS | 2003 | In-hospital | 2.3% AF vs 0.6% no AF | N/A | N/A | N/A | N/A | 34.8% vs 16.6% | 15.7% vs 6.1% | 27.3% vs 14.7% |
| Mehta/GRACE | 2003 | In-hospital | OR 1.33(0.80-2.20) | 12.5 days vs 7.8 days | OR 2.0(1.37-2.93) | OR 1.64(1.25-2.14) | OR 2.83(2.27-3.52) | OR 2.4(1.88-3.06) | OR 1.97(1.56-1.25) | |
| Goldberg | 2002 | N/A | N/A | N/A | N/A | N/A | 55% vs 27% | 12.8% vs 5.9% | N/A | N/A |
| Al-Khatib/PURSUIT | 2001 | 6 months | HR 2.9(1.7-4.8) | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Pizetti/GISSI-III | 2001 | In-hospital | Not Significant | 15 days vs 13 days | N/A | N/A | 51.5% vs 23.6% | N/A | 4.3% vs 1.9% | 4.4% vs 2.3% |
| Rathore/CCP | 2000 | In-hospital | 2.8% AF vs 1.7% no AF | 11 days vs 7.6 days | 4.4% vs 3.6% | N/A | 60.1% vs 42.2% | N/A | N/A | N/A |
| Wong(17)/GUSTO-III | 2000 | 30 days | 4% AF vs 2% no AF | N/A | 9% vs 4% | N/A | 44% vs 14% | 14% vs 3% | 10% vs 3% | 10% vs 4% |
| Pedersen(33)/TRACE | 1999 | N/A | N/A | N/A | N/A | N/A | 48% vs 34% | 6% vs 3% | 18% vs 11% | 11% vs 6% |
| Eldar | 1998 | In-hospital | OR 4.6(1.9-10.8) | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Crenshaw/GUSTO-I | 1997 | In-hospital | 3.1% AF vs 1.3% no AF | 14.3 days vs 10 days | 8% vs 4% | N/A | 39% vs 14% | 16% vs 5% | 16% vs 5% | 15% vs 6% |
| Sakata | 1997 | N/A | N/A | N/A | N/A | N/A | 63% vs 30% | 44% vs 25% | N/A | N/A |